Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 04, 2022

BUY
$0.24 - $1.11 $3,170 - $14,665
13,212 New
13,212 $4,000
Q2 2022

Aug 01, 2022

SELL
$0.41 - $0.91 $11,309 - $25,100
-27,583 Closed
0 $0
Q1 2022

May 10, 2022

SELL
$0.79 - $1.59 $5,296 - $10,660
-6,705 Reduced 19.55%
27,583 $22,000
Q4 2021

Feb 08, 2022

SELL
$1.36 - $2.94 $193 - $417
-142 Reduced 0.41%
34,288 $46,000
Q3 2021

Nov 12, 2021

SELL
$2.97 - $4.84 $14,273 - $23,261
-4,806 Reduced 12.25%
34,430 $104,000
Q2 2021

Aug 13, 2021

BUY
$3.71 - $5.13 $27,235 - $37,659
7,341 Added 23.02%
39,236 $181,000
Q1 2021

May 14, 2021

BUY
$4.08 - $14.75 $7,290 - $26,358
1,787 Added 5.94%
31,895 $137,000
Q4 2020

Feb 09, 2021

BUY
$11.06 - $14.01 $103,322 - $130,881
9,342 Added 44.99%
30,108 $333,000
Q3 2020

Nov 13, 2020

SELL
$10.26 - $14.55 $23,403 - $33,188
-2,281 Reduced 9.9%
20,766 $251,000
Q2 2020

Aug 03, 2020

BUY
$7.11 - $13.76 $59,645 - $115,432
8,389 Added 57.23%
23,047 $317,000
Q1 2020

May 15, 2020

SELL
$5.71 - $15.85 $64,859 - $180,040
-11,359 Reduced 43.66%
14,658 $113,000
Q4 2019

Feb 12, 2020

SELL
$9.6 - $17.75 $25,747 - $47,605
-2,682 Reduced 9.35%
26,017 $397,000
Q3 2019

Nov 12, 2019

BUY
$12.16 - $21.0 $54,440 - $94,017
4,477 Added 18.48%
28,699 $349,000
Q2 2019

Aug 13, 2019

SELL
$9.44 - $19.8 $30,963 - $64,944
-3,280 Reduced 11.93%
24,222 $480,000
Q1 2019

May 15, 2019

BUY
$11.11 - $13.49 $2,266 - $2,751
204 Added 0.75%
27,502 $337,000
Q4 2018

Feb 14, 2019

SELL
$10.24 - $15.49 $52,551 - $79,494
-5,132 Reduced 15.82%
27,298 $346,000
Q3 2018

Nov 14, 2018

BUY
$15.53 - $19.97 $2,966 - $3,814
191 Added 0.59%
32,430 $504,000
Q2 2018

Aug 13, 2018

BUY
$15.88 - $19.5 $39,048 - $47,950
2,459 Added 8.26%
32,239 $602,000
Q1 2018

May 14, 2018

SELL
$13.53 - $17.47 $34,068 - $43,989
-2,518 Reduced 7.8%
29,780 $507,000
Q4 2017

Feb 14, 2018

BUY
$14.41 - $19.15 $465,414 - $618,506
32,298
32,298 $514,000

Others Institutions Holding ATNX

About Athenex, Inc.


  • Ticker ATNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 156,790,000
  • Market Cap $1.57M
  • Description
  • Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...
More about ATNX
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.